Dr. Hariri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans St
Baltimore, MD 21287
Summary
- After graduating as an M.D. from the Lebanese American University, I completed a postdoctoral research fellowship, sponsored by NIH under a TL1 grant, at the University of Massachusetts (UMass) Medical School in the field of Interventional Cardiology. Moreover, I graduated from the Graduate School of Biomedical Sciences at UMass with a Masters degree in Clinical Investigation (MSCI).
I finished Internal Medicine residency and chief residency at Cleveland Clinic, OH, and I'm currently a Cardiology Fellow at Johns Hopkins.
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2023 - 2027
University of MassachusettsMasters of Sciences in Clinical Investigation (MSCI), Cardiology, 2017
Cleveland Clinic FoundationResidency, Internal Medicine, 2019 - 2022
UMass Chan Medical SchoolPost-Doctoral Fellowship, Cardiovascular Disease, 2017 - 2019
Lebanese American University Gilbert and Rose-Marie Chagoury School of MedicineClass of 2017- Lebanese American University - School of Arts and SciencesBS, Biology, Valedictorian, 2010 - 2013
Certifications & Licensure
MD State Medical License 2023 - 2026
OH State Medical License 2019 - 2024- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- EPI Early Career Travel Award Council on Epidemiology and Prevention’s Early Career Committee, American Heart Association (AHA), 2018
- National Institute of Health (NIH) TL1 Training Grant UMass Center for Clinical and Translational Science (UMCCTS), 2017
Clinical Trials
- Vitamin K2 Supplementation and Arterial Stiffness in the Renal Transplant Population (The KING Trial) Start of enrollment: 2015 Mar 01
- Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function Start of enrollment: 2015 Oct 24
Publications & Presentations
PubMed
- A Case-Based Approach to the Management of Patients with Chronic Coronary Disease: Updates from the 2023 AHA/ACC Guidelines.Yoo Jin Kim, Jasmine Malhi, Jeff Trost, Thorsten Leucker, Salim S Virani
The American Journal of Medicine. 2024-09-14 - The Effect of Eicosapentaenoic and Docosahexaenoic Acid Supplementation on Coronary Artery Calcium Progression in Subjects With Diabetes and Coronary Artery Disease: A...Abdul Aziz Asbeutah, Ralph Daher, Abdulaziz Malik, Essa Hariri, Abdulhamied Alfaddagh
The American Journal of Cardiology. 2024-08-15 - 1 citationsRole of aortic valve replacement in moderate aortic stenosis: a 10-year outcomes study.Essa H Hariri, Osamah Badwan, Joseph Kassab, Habib Layoun, Warren Skoza
Open Heart. 2024-05-20
Journal Articles
- Irritable bowel syndrome: prevalence, risk factors in an adult Lebanese populationRajaa Chatila, Mahmoud Merhi, Essa Hariri, Nada Sabbah and Mary E. Deeb, BMC Gastroenterology, 11/2017
Press Mentions
Aspirin Use Tied to Slower AAA ProgressionDecember 22nd, 2023
Grant Support
- National Institute of Health (NIH) TL1 Training GrantUniversity of Massachusetts Medical School2017–2019
Other Languages
- Arabic
External Links
- Academia.eduhttps://clevelandclinic.academia.edu/EssaHariri
- Linkedinhttps://www.linkedin.com/in/essa-hariri-4059603a/
- Research Gatehttps://www.researchgate.net/profile/Essa_Hariri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
